1. Home
  2. PESI vs GBIO Comparison

PESI vs GBIO Comparison

Compare PESI & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PESI
  • GBIO
  • Stock Information
  • Founded
  • PESI 1990
  • GBIO 2016
  • Country
  • PESI United States
  • GBIO United States
  • Employees
  • PESI N/A
  • GBIO N/A
  • Industry
  • PESI Environmental Services
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • PESI Industrials
  • GBIO Health Care
  • Exchange
  • PESI Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • PESI 191.9M
  • GBIO 64.8M
  • IPO Year
  • PESI 1992
  • GBIO 2020
  • Fundamental
  • Price
  • PESI $10.68
  • GBIO $0.88
  • Analyst Decision
  • PESI Strong Buy
  • GBIO Strong Buy
  • Analyst Count
  • PESI 1
  • GBIO 2
  • Target Price
  • PESI $18.00
  • GBIO $6.50
  • AVG Volume (30 Days)
  • PESI 139.0K
  • GBIO 581.0K
  • Earning Date
  • PESI 03-12-2025
  • GBIO 03-05-2025
  • Dividend Yield
  • PESI N/A
  • GBIO N/A
  • EPS Growth
  • PESI N/A
  • GBIO N/A
  • EPS
  • PESI N/A
  • GBIO N/A
  • Revenue
  • PESI $67,134,000.00
  • GBIO $18,582,000.00
  • Revenue This Year
  • PESI N/A
  • GBIO $212.74
  • Revenue Next Year
  • PESI $52.66
  • GBIO N/A
  • P/E Ratio
  • PESI N/A
  • GBIO N/A
  • Revenue Growth
  • PESI N/A
  • GBIO 514.08
  • 52 Week Low
  • PESI $7.63
  • GBIO $0.75
  • 52 Week High
  • PESI $16.25
  • GBIO $4.65
  • Technical
  • Relative Strength Index (RSI)
  • PESI 40.98
  • GBIO 28.66
  • Support Level
  • PESI $10.10
  • GBIO $0.85
  • Resistance Level
  • PESI $10.79
  • GBIO $1.01
  • Average True Range (ATR)
  • PESI 0.51
  • GBIO 0.12
  • MACD
  • PESI 0.07
  • GBIO 0.00
  • Stochastic Oscillator
  • PESI 46.03
  • GBIO 7.50

About PESI Perma-Fix Environmental Services Inc.

Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: Treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: